Prof. Joel BrindJoel Brind

General Biology and Endocrinology

Email: joelbrind@yahoo.com
Phone: (646) 660-6240
Location: Rm 608A, 17 Lexington Ave

 

JOEL BRIND, PhD, graduated Yale College in 1971 and earned his doctorate from New York University in 1981 in Basic Medical Sciences, with specialization in biochemistry, physiology and immunology. Since 1986, he has been a professor of human biology and endocrinology at Baruch College of the City University of New York.

During the 1980s, he specialized in the metabolism of steroid hormones and their relation to various human diseases, including breast cancer. He pursued this research mainly with the Orentreich Foundation for the Advancement of Science, full-time from 1981-86, and part time as a consultant between 1986 and 2014.

Since coming across evidence linking abortion and breast cancer in1992, Dr. Brind has been known mostly for his research effort in studying what has come to be known as the “ABC link”, compiling and publishing critical reviews on the subject in1996, 2005 and 2018 in peer-reviewed medical journals. In 1999, Dr.Brind co-founded the nonprofit Breast Cancer Prevention Institute (of which he remains on the Board of Directors), now headquartered in Somerville, New Jersey (www.bcpinstitute.org). From 2003–2006, he served as a member of the Federal government’s CDC advisory committee on the early detection and control of breast and cervical cancer. Dr. Brind continues to analyze and conduct reviews of studies on the ABC link, as studies evidencing the link continue to emerge, mostly from China and South Asia.

Dr. Brind was also lead author of a 2015 systematic review and meta-analysis on the link between the injectable contraceptive DMPA and increased risk of acquiring HIV. Such evidence has finally (early 2017) been recognized by the World Health Organization, whose latest “Guidance statement” now stipulates: “there must be clear provision of information beforehand to enable informed decision-making” re: the use of DMPA for women at high risk of acquiring HIV.

Since 2007 Dr. Brind has also been studying amino acid metabolism in the context of nutrition and aging.

2010 he founded Natural Food Science, LLC, which makes and markets the supplement sweetamine® (www.sweetamine.com), based on his research conclusion that the amino acid glycine is the body’s most important regulator of inflammation, and that a dietary deficiency in this amino acid is largely responsible for most chronic disease (including diabetes, cancer and cardiovascular disease) rooted in chronic inflammation.

sample PUBLICATIONS

Brind J. Rapid response re: Autism spectrum disorder: Advances in diagnosis and treatment. BMJ 2018;361:k1674. doi: https://doi.org/10.1136/bmj.k1674 (Published 21 May 2018)


Brind J. Rapid response re: Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ 2018;361:k1036
doi: https://doi.org/10.1136/bmj.k1036 (Published 23 April 2018)

Brind J. Rapid response re: Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ 2018;360:k134 doi: https://doi.org/10.1136/bmj.k134 (Published 31 January 2018)

Brind J, Condly SC, Lanfranchi A, Rooney B. Induced abortion as an independent risk factor for breast cancer: A systematic review and meta-analysis of studies on South Asian women. Issues Law Med 2018;33:33-54.

Brind J, Condly SJ, Mosher SW, Morse AR, Kimball J. (2015) Risk of HIV infection in Depot-Medroxyprogesterone Acetate (DMPA) Users: A Systematic Review and Meta-Analysis. Issues Law Med 2015;30:129-39.

Brind J (2007) Scientific developments relating to the effect of abortion on risk of future breast cancer. Memorandum 14: House of Commons (UK) Science and Technology Committee re: Scientific Develop-ments Relating to the Abortion Act of 1967. London: The Stationery Office, 2007, pp. Ev 96-Ev 101.

Lanfranchi A, Brind J. Breast cancer risks and prevention (1st Ed., 2003, 2nd Ed., 2004, 3rd Ed., 2005, 4th Ed., 2007). Poughkeepsie,NY: Breast Cancer Prevention Institute 29 pp.

Brind J (2005) Induced abortion as an independent risk factor for breast cancer: A critical review of recent studies based on prospective data. J Am Physicians Surg 10:105-10

Brind J, Chinchilli VM, Severs WB, Summy-Long J (1996) Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J Epidemiol Community Health 50:481-96.

Brind J, Borofsky N, Chervinsky K, Vogelman JH, Orentreich N (1996) A simple, differential extraction method for the simultaneous direct radioimmunoassay of androgens and androgen glucuronides in human serum. Steroids 61:429-32.

Brind J (1996) Spotlight on DHEA: A marker for progression of HIV infection? (editorial) J Lab Clin Med 127:522-3.
Brind J, Strain G, Miller L, Zumoff B, Vogelman JH, Orentreich N (1990) Obese men have elevated levels of estrone sulfate. Int J Obesity 14:483-6

Brind JL, Chervinsky K, Völgelman JH, Orentreich N. (1990) Radioimmunoassay of estrone sulfate in the serum of normal men after a non-chromatographic procedure that eliminates interference from dehydroepiandrosterone sulfate.
Steroids 55:32-5.

Brind JL, Chervinsky K, Vogleman JH, Orentreich N. (1989) Radioimmunoassay of estrone sulfate in the serum of normal men after a chromatographic procedure that eliminates dehydroepiandrosterone sulfate interference. Steroids 54:21-35.

Brind JL, Kuo SW, Chervinsky K, Fitzgerald K, Orentreich N. (1985) A new partition thin-layer chromatographic method for steroid separations. Steroids 45:565-71.

Brind JL, Marinescu D, Gomez EC, Wheatley VR, Orenteich N. (1984) In-vitro testosterone metabolism in the mouse preputial gland: intercellular co-operation and changes with cell maturation. J Endocrinol 100:377-88.

The City University of New York